For: | Zhao WH, Ma ZM, Zhou XR, Feng YZ, Fang BS. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World J Gastroenterol 2002; 8(2): 237-242 [PMID: 11925599 DOI: 10.3748/wjg.v8.i2.237] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v8/i2/237.htm |
Number | Citing Articles |
1 |
Li-Wang Zhang, Jun Ren, Liang Zhang, Hong-Mei Zhang, Bin Jin, Bo-Rong Pan, Xiao-Ming Si, Yan-Jun Zhang, Zhong-Hua Wang, Yang-Lin Pan, Stephen M Festein. Construction and expression of recombined human AFP eukaryotic expression vector. World Journal of Gastroenterology 2003; 9(7): 1465-1468 doi: 10.3748/wjg.v9.i7.1465
|
2 |
Lun-Xiu Qin, Zhao-You Tang. The prognostic molecular markers in hepatocellular carcinoma. World Journal of Gastroenterology 2002; 8(3): 385-392 doi: 10.3748/wjg.v8.i3.385
|
3 |
T.W. Chen, C.M. Chu, J.C. Yu, C.J. Chen, D.C. Chan, Y.C. Liu, C.B. Hsieh. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy. European Journal of Surgical Oncology (EJSO) 2007; 33(4): 480 doi: 10.1016/j.ejso.2006.10.012
|
4 |
|
5 |
Chunli Kong, Zhongwei Zhao, Weiyue Chen, Xiuling Lv, Gaofeng Shu, Miaoqing Ye, Jingjing Song, Xihui Ying, Qiaoyou Weng, Wei Weng, Shiji Fang, Minjiang Chen, Jianfei Tu, Jiansong Ji. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE. European Radiology 2021; 31(10): 7500 doi: 10.1007/s00330-021-07910-0
|
6 |
Da Xu, Jessica Qiuhua Sheng, Paul Jen-Hwa Hu, Ting Shuo Huang, Wei-Chen Lee. Predicting hepatocellular carcinoma recurrences: A data-driven multiclass classification method incorporating latent variables. Journal of Biomedical Informatics 2019; 96: 103237 doi: 10.1016/j.jbi.2019.103237
|
7 |
Stacey Prenner, Laura Kulik. Zakim and Boyer's Hepatology. 2018; : 668 doi: 10.1016/B978-0-323-37591-7.00046-X
|
8 |
C. CAMMÀ, V. DI MARCO, G. CABIBBO, F. LATTERI, L. SANDONATO, P. PARISI, M. ENEA, M. ATTANASIO, M. GALIA, N. ALESSI, A. LICATA, M. A. LATTERI, A. CRAXÌ. Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems. Alimentary Pharmacology & Therapeutics 2008; 28(1): 62 doi: 10.1111/j.1365-2036.2008.03692.x
|
9 |
Bruno Daniele, Francesco Perrone. Staging for Liver Cancer. Clinics in Liver Disease 2005; 9(2): 213 doi: 10.1016/j.cld.2004.12.003
|
10 |
Sene Waly Raphael, Zhang Yangde, Chen YuXiang. Hepatocellular Carcinoma: Focus on Different Aspects of Management. ISRN Oncology 2012; 2012: 1 doi: 10.5402/2012/421673
|
11 |
Shao-Hua Peng, Hong Deng, Jian-Feng Yang, Ping-Ping Xie, Cheng Li, Hao Li, De-Yun Feng. Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues. World Journal of Gastroenterology 2005; 11(41): 6521-6524 doi: 10.3748/wjg.v11.i41.6521
|
12 |
Zhao-Chong Zeng, Guo-Liang Jiang, Guo-Min Wang, Zhao-You Tang, Walter J. Curran, George Iliakis. DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line. World Journal of Gastroenterology 2002; 8(5): 797-803 doi: 10.3748/wjg.v8.i5.797
|
13 |
Wen-Jiao Zeng, Guo-Yuan Liu, Jie Xu, Xin-Da Zhou, Yue-E Zhang, Nong Zhang. Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma. World Journal of Gastroenterology 2002; 8(6): 1040-1044 doi: 10.3748/wjg.v8.i6.1040
|
14 |
Jonathan Olesinski, François Mithieux, Olivier Guillaud, Marie-Noëlle Hilleret, Catherine Lombard-Bohas, Luc Henry, Olivier Boillot, Thomas Walter, Christian Partensky, Pierre Paliard, Pierre-Jean Valette, Jean-Philippe Vuillez, Françoise Borson-Chazot, Jean-Yves Scoazec, Jérôme Dumortier. Survival and prognostic factors after adjuvant 131iodine-labeled lipiodol for hepatocellular carcinoma: a retrospective analysis of 106 patients over 20 years. Annals of Nuclear Medicine 2017; 31(5): 379 doi: 10.1007/s12149-017-1165-4
|
15 |
E. Giannini, D. Risso, F. Botta, P. Romagnoli, F. Malfatti, A. Fumagalli, E. Testa, E. Podestà, B. Chiarbonello, S. Polegato, R. Testa. Prognosis of hepatocellular carcinoma in anti‐HCV positive cirrhotic patients: a single‐centre comparison amongst four different staging systems. Journal of Internal Medicine 2004; 255(3): 399 doi: 10.1046/j.1365-2796.2003.01284.x
|
16 |
Clifford S. Cho, Mithat Gonen, Jinru Shia, Michael W. Kattan, David S. Klimstra, William R. Jarnagin, Michael I. D’Angelica, Leslie H. Blumgart, Ronald P. DeMatteo. A Novel Prognostic Nomogram Is More Accurate than Conventional Staging Systems for Predicting Survival after Resection of Hepatocellular Carcinoma. Journal of the American College of Surgeons 2008; 206(2): 281 doi: 10.1016/j.jamcollsurg.2007.07.031
|
17 |
Ji Yeon Seo, Won Kim, Jee Hye Kwon, Eun Hyo Jin, Su Jong Yu, Hwi Young Kim, Yong Jin Jung, Donghee Kim, Yoon Jun Kim, Jung‐Hwan Yoon, Hyo‐Suk Lee. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B‐related hepatocellular carcinoma following radiofrequency ablation. Liver International 2013; 33(6): 884 doi: 10.1111/liv.12132
|
18 |
Morris Sherman. Staging for hepatocellular carcinoma. Current Hepatitis Reports 2004; 3(2): 61 doi: 10.1007/s11901-004-0011-z
|
19 |
Jiliang Feng, Junmei Chen, Ruidong Zhu, Lu Yu, Yan Zhang, Dezhao Feng, Heli Kong, Chenzhao Song, Hui Xia, Jushan Wu, Dawei Zhao. Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection. Oncotarget 2017; 8(38): 63299 doi: 10.18632/oncotarget.18799
|
20 |
Giovanni Ramacciato, Paolo Mercantini, Nicola Cautero, Nicola Corigliano, Fabrizio Di Benedetto, Cristiano Quintini, Giorgio Ercolani, Giovanni Varotti, Vincenzo Ziparo, Antonio Daniele Pinna. Prognostic Evaluation of the New American Joint Committee on Cancer/International Union Against Cancer Staging System for Hepatocellular Carcinoma: Analysis of 112 Cirrhotic Patients Resected for Hepatocellular Carcinoma. Annals of Surgical Oncology 2005; 12(4): 289 doi: 10.1245/ASO.2005.03.098
|
21 |
Fu-Ping Zhong, Yu-Jun Zhang, Ying Liu, Shu-Bing Zou. Prognostic impact of surgical margin in patients with hepatocellular carcinoma. Medicine 2017; 96(37): e8043 doi: 10.1097/MD.0000000000008043
|
22 |
Antony Lawrence Gough-Palmer, Wladyslaw Michal Witold Gedroyc. Laser ablation of hepatocellular carcinoma-A review. World Journal of Gastroenterology 2008; 14(47): 7170-7174 doi: 10.3748/wjg.14.7170
|
23 |
Yun-Le Wan, Shu-Sen Zheng, Zhi-Cheng Zhao, Min-Wei Li, Chang-Ku Jia, Hao Zhang. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity. World Journal of Gastroenterology 2004; 10(2): 195-199 doi: 10.3748/wjg.v10.i2.195
|
24 |
N Griffin, H Addley, E Sala, A S Shaw, L A Grant, H Eldaly, S E Davies, T Prevost, G J Alexander, D J Lomas. Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI?. The British Journal of Radiology 2012; 85(1014): 736 doi: 10.1259/bjr/94924398
|
25 |
Jay L. Grosfeld, Jean-Bernard Otte. The Surgery of Childhood Tumors. 2008; : 227 doi: 10.1007/978-3-540-29734-5_12
|
26 |
S Wildi, B C Pestalozzi, L McCormack, P-A Clavien. Critical evaluation of the different staging systems for hepatocellular carcinoma. British Journal of Surgery 2004; 91(4): 400 doi: 10.1002/bjs.4554
|
27 |
Melanie B. Thomas, Romil Chadha, Katrina Glover, Xuemei Wang, Jeffrey Morris, Thomas Brown, Asif Rashid, Janet Dancey, James L. Abbruzzese. Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma . Cancer 2007; 110(5): 1059 doi: 10.1002/cncr.22886
|
28 |
M.C. Jansen, R. van Hillegersberg, R.A.F.M. Chamuleau, O.M. van Delden, D.J. Gouma, T.M. van Gulik. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. European Journal of Surgical Oncology (EJSO) 2005; 31(4): 331 doi: 10.1016/j.ejso.2004.10.011
|
29 |
Charing Ching-Ning Chong, Kit-fai Lee, Philip Ching-Tak Ip, Jeff Siu-Wang Wong, Sunny Yue-Sun Cheung, John Wong, Suzanne C. Ho, Paul Bo-San Lai. Pre-operative predictors of post-hepatectomy recurrence of hepatocellular carcinoma: Can we predict earlier?. The Surgeon 2012; 10(5): 260 doi: 10.1016/j.surge.2011.07.004
|
30 |
Nouha Dilou, Brigitte Patouillard, Jean-Christian Audigier. Les classifications de prédiction de survie du carcinome hépatocellulaire. Gastroentérologie Clinique et Biologique 2004; 28(4): 359 doi: 10.1016/S0399-8320(04)94936-6
|
31 |
Irene Bargellini. Hepatocellular carcinoma: MR staging and therapeutic decisions. Abdominal Imaging 2012; 37(2): 231 doi: 10.1007/s00261-011-9735-8
|
32 |
Benyam D. Addissie, Lewis R. Roberts. Classification and Staging of Hepatocellular Carcinoma. Clinics in Liver Disease 2015; 19(2): 277 doi: 10.1016/j.cld.2015.01.011
|
33 |
Ken Shirabe, Kiyoshi Kajiyama, Norifumi Harimoto, Hideaki Masumoto, Tatsuro Fukuya, Masafumi Ooya, Yoshihiko Maehara. Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion. World Journal of Gastroenterology 2009; 15(21): 2632-2637 doi: 10.3748/wjg.15.2632
|
34 |
Alfredo Guglielmi, Andrea Ruzzenente, Marco Sandri, Silvia Pachera, Corrado Pedrazzani, Sebastiano Tasselli, Calogero Iacono. Radio Frequency Ablation for Hepatocellular Carcinoma in Cirrhotic Patients: Prognostic Factors for Survival. Journal of Gastrointestinal Surgery 2007; 11(2): 143 doi: 10.1007/s11605-006-0082-y
|
35 |
Kit Fai Lee, Ching Ning Chong, Jeff Wong, Yue Sun Cheung, John Wong, Paul Lai. Long‐Term Results of Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma: A Case‐Matched Analysis. World Journal of Surgery 2011; 35(10): 2268 doi: 10.1007/s00268-011-1212-6
|
36 |
Wu Ji, Jie-Shou Li, Ling-Tang Li, Wu-Hong Liu, Kuan-Sheng Ma, Xiang-Tian Wang, Zhen-Ping He, Jia-Hong Dong. Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinoma. World Journal of Gastroenterology 2003; 9(8): 1702-1706 doi: 10.3748/wjg.v9.i8.1702
|
37 |
Ahmed Gabr, Nadine Abouchaleh, Rehan Ali, Michael Vouche, Rohi Atassi, Khairuddin Memon, Ali Al Asadi, Talia Baker, Juan Carlos Caicedo, Kush Desai, Jonathan Fryer, Ryan Hickey, Michael Abeccassis, Ali Habib, Elias Hohlastos, Daniel Ganger, Laura Kulik, Robert J. Lewandowski, Ahsun Riaz, Riad Salem. Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization. European Journal of Radiology 2017; 93: 100 doi: 10.1016/j.ejrad.2017.05.022
|
38 |
Ivan Fan-Ngai Hung, Danny Ka-Ho Wong, Ronnie Tung-Ping Poon, Daniel Yee-Tak Fong, Ada Hang-Wai Chui, Wai-Kay Seto, James Yan-Yue Fung, Albert Chi-Yan Chan, John Chi-Hang Yuen, Randal Tiu, Olivia Choi, Ching-Lung Lai, Man-Fung Yuen, Ming-Lung Yu. Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma. PLOS ONE 2016; 11(2): e0148493 doi: 10.1371/journal.pone.0148493
|
39 |
Ferenc Szalay, Mónika B Hantos, Andrea Horvath, Peter L. Lakatos, Aniko Folhoffer, Kinga Dunkel, Dalma Hegedus, Kornélia Tekes. Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma. World Journal of Gastroenterology 2004; 10(1): 42-45 doi: 10.3748/wjg.v10.i1.42
|
40 |
Zhi-Ming Li, Zong-Chao Liu, Zhong-Zhen Guan, Xiao-Feng Zhu, Jun-Min Zhou, Bing-Fen Xie, Gong-Kan Feng, Zhen-Yu Zhu, Wen-Qi Jiang. Inhibition of DNA primase and induction of apoptosis by 3,3’-diethyl-9-methylthia-carbocyanine iodide in hepatocellular carcinoma BEL-7402 cells. World Journal of Gastroenterology 2004; 10(4): 514-520 doi: 10.3748/wjg.v10.i4.514
|
41 |
Shao-Shan Wang, Ti Zhang, Xi-Lu Wang, Li Hong, Qing-Hui Qi. Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity. World Journal of Gastroenterology 2003; 9(5): 930-935 doi: 10.3748/wjg.v9.i5.930
|
42 |
Chunwang Yuan, Zhenchang Wang, Dongsheng Gu, Jie Tian, Peng Zhao, Jingwei Wei, Xiaozhen Yang, Xiaohan Hao, Di Dong, Ning He, Yu Sun, Wenfeng Gao, Jiliang Feng. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram. Cancer Imaging 2019; 19(1) doi: 10.1186/s40644-019-0207-7
|
43 |
Emanuel Shapera, Kaitlyn Crespo, Cameron Syblis, Sharona Ross, Alexander Rosemurgy, Iswanto Sucandy. Robotic liver resection for hepatocellular carcinoma: analysis of surgical margins and clinical outcomes from a western tertiary hepatobiliary center. Journal of Robotic Surgery 2022; 17(2): 645 doi: 10.1007/s11701-022-01468-9
|
44 |
Claudio Maurizio Pacella, Giampiero Francica, Giovanni Giuseppe Di Costanzo. Laser Ablation for Small Hepatocellular Carcinoma. Radiology Research and Practice 2011; 2011: 1 doi: 10.1155/2011/595627
|
45 |
Yoshito Tomimaru, Hidetoshi Eguchi, Hiroshi Wada, Shogo Kobayashi, Shigeru Marubashi, Masahiro Tanemura, Koji Umeshita, Tonsok Kim, Kenichi Wakasa, Yuichiro Doki, Masaki Mori, Hiroaki Nagano. IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma. International Journal of Cancer 2012; 130(2): 319 doi: 10.1002/ijc.25994
|
46 |
Mitsuru Ishizuka, Keiichi Kubota, Junji Kita, Mitsugi Shimoda, Masato Kato, Tokihiko Sawada. Survival after surgery for hepatocellular carcinoma in relation to presence or absence of viral infection. The American Journal of Surgery 2013; 206(2): 187 doi: 10.1016/j.amjsurg.2012.08.011
|
47 |
A. Nanashima, S. Morino, H. Yamaguchi, K. Tanaka, S. Shibasaki, T. Tsuji, S. Hidaka, T. Sawai, T. Yasutake, T. Nakagoe. Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinoma. European Journal of Surgical Oncology (EJSO) 2003; 29(9): 735 doi: 10.1016/j.ejso.2003.08.007
|
48 |
Alfredo Guglielmi, Andrea Ruzzenente, Silvia Pachera, Alessandro Valdegamberi, Marco Sandri, Mirko D'Onofrio, Calogero Iacono. Comparison of Seven Staging Systems in Cirrhotic Patients With Hepatocellular Carcinoma in a Cohort of Patients Who Underwent Radiofrequency Ablation With Complete Response. The American Journal of Gastroenterology 2008; 103(3): 597 doi: 10.1111/j.1572-0241.2007.01604.x
|
49 |
Anne M. Larson, Matthew Hauswald. Diseases of the Liver in Children. 2014; : 23 doi: 10.1007/978-1-4614-9005-0_2
|
50 |
Sha Huang, Gui-Qian Huang, Gui-Qi Zhu, Wen-Yue Liu, Jie You, Ke-Qing Shi, Xiao-Bo Wang, Han-Yang Che, Guo-Liang Chen, Jian-Feng Fang, Yi Zhou, Meng-Tao Zhou, Yong-Ping Chen, Martin Braddock, Ming-Hua Zheng, Chien-Wei Su. Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection. PLOS ONE 2015; 10(6): e0129000 doi: 10.1371/journal.pone.0129000
|
51 |
Bruno Daniele, Mena Annunziata, Emiddio Barletta, Vincenza Tinessa, Massimo Di Maio. Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinoma. Hepatology Research 2007; 37(s2) doi: 10.1111/j.1872-034X.2007.00186.x
|
52 |
Yajuan Sun, Can Yu, Xinxin Wang, Rui Yang, ZhiPeng Ding, Yang Zhou. Establishment and Validation of the LI-RADS Morphologic Type II Hepatocellular Carcinoma Early Recurrence Risk Scoring System. Journal of Gastrointestinal Surgery 2023; 27(12): 2787 doi: 10.1007/s11605-023-05873-9
|
53 |
Ken Shirabe, Kiyoshi Kajiyama, Tomoyuki Abe, Shigeru Sakamoto, Tatsuro Fukuya, Kohei Akazawa, Kazutoyo Morita, Yoshihiko Maehara. Predictors of microscopic portal vein invasion by hepatocellular carcinoma: Measurement of portal perfusion defect area ratio. Journal of Gastroenterology and Hepatology 2009; 24(8): 1431 doi: 10.1111/j.1440-1746.2009.05847.x
|
54 |
Lian-Xin Liu, Zhi-Hua Liu, Hong-Chi Jiang, Wei-Hui Zhang, Shu-Yi Qi, Jie Hu, Xiu-Qin Wang, Min Wu. Gene expression profiles of hepatoma cell line HLE. World Journal of Gastroenterology 2003; 9(4): 683-687 doi: 10.3748/wjg.v9.i4.683
|